Annual Monograph Update Meetings Would Boost Transparency – Bayer
This article was originally published in The Tan Sheet
Executive Summary
Bayer HealthCare LLC’s Consumer Care unit says 9 comments to FDA that an annual monograph update meeting should include the agency’s Nonprescription Drug Advisory Committee to provide feedback on topics.